Page 52 - Exact Sciences News Today

There’s an interesting discussion taking place in Wisconsin’s southern neighbor. The Illinois Legislature is considering a bill aimed at protecting children on social media.

Exact Sciences (NASDAQ:EXAS) Corporation earned a price target raise from Canaccord Genuity (TSX:CF, LSE:CF) after the molecular diagnostics company...

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target lifted by analysts at Piper Sandler from $70.00 to $80.00 in a research note issued to investors on Monday, The Fly reports. Piper Sandler’s target price points to a potential upside of 1.02% from the company’s previous close. EXAS has been the subject of several […]

Diagnostic and cancer test products provider Exact Sciences Corp. NASDAQ: EXAS saw its shares spike over 17% on its Q1 2023 earnings results. The company is…

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a report issued on Wednesday morning, The Fly reports. Several other brokerages also recently issued reports on EXAS. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target hoisted by BTIG Research from $80.00 to $90.00 in a report released on Wednesday, The Fly reports. A number of other equities research analysts have also weighed in on EXAS. SVB Leerink lifted their target price on shares of Exact Sciences from $70.00 to $75.00 […]

This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right.

California Public Employees Retirement System lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 328,773 shares of the medical research company’s stock after selling 32,149 […]

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective boosted by Stifel Nicolaus from $75.00 to $85.00 in a report published on Wednesday, The Fly reports. EXAS has been the topic of a number of other research reports. Raymond James downgraded Exact Sciences from an outperform rating to a market perform rating in a […]

This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right.